ACT

FEB. 2/2016

Advertisment

news roundup

Update on Phase I Trial Death in France

French safety authority confirms what had been speculated—Phase I volunteers received the highest dose escalation at the same time, going against EMA recommendations.


Tufts: Sponsors Innovate on Recruitment

New approaches include using Big Data to identify and understand patient populations.

advertisment

Q1 Patient Centric Clinical Innovation Conference
Integrating patients into clinical research from study design to enrollment and retention to streamline research, reducing study delays through patient centric approaches that create partnerships between patients & industry. Presenters include Executive Leadership from Sanofi, EMD Serono, Janssen, Pfizer, BMS, Shire, Roche, Bayer, GSK, Merck, Novartis & More. Conference dates of March 3-4 in Philadelphia.
Register now


Oracle Joins SCRS as Global Impact Partner

Oracle will participate on the SCRS Global Impact Board at an executive level, and help determine strategic initiatives for SCRS.

Bioclinica Launches Post-Approval Division

Bioclinica builds post-approval study-specific technology platform with a Program Coordinating Center (PCC) of experienced post-approval research staff.

In this edition

Tufts: Sponsors Innovate on Recruitment
EU’s Challenge to Pay for Research
Trial Transparency: PR Hype or Added Value?
Oncology Update—Cancer MoonShot Will Enroll 20,000

Subscribe

Subscribe

Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »


Events


articles

Trial Transparency: PR Hype or Added Value?

The downstream benefits should provide a platform to ensure greater ethical clarity in our development of healthcare products.

Advertisment

Blog Posts

EU’s Challenge to Pay for Research

EU authorities have been keeping up a constant flow of reminders of just how valuable research programs are in terms of improving industry's capacity to innovate.


advertisment

CBI’s Clinical Technologies Conference, taking place this March in Philadelphia.
CBI’s Clinical Technology Congress offers the opportunity for clinical executives to gain insight into utilizing technology to enable efficient, cost-effective trials while maintaining data control. With a focus on process and data stewardship, attendees walk away with best practices to streamline trial execution through enabling technology at the sponsor/CRO, research site and patient level.
Learn more

Oncology

Cancer MoonShot Will Enroll 20,000 in Trials

The coalition aims to use a secure cloud-based infrastructure to complete randomized clinical trials in patients with cancer at all stages of disease, in 20 tumor types.


Meeting the Unique Challenges of Orphan Drug Development

Treatment often involves multiple specialties such as neurology, gastroenterology, psychiatry, endocrinology, cardiology and physical therapy because clinically important comorbidities are common.


Marketplace

DIA 2016 brings together global thought leaders and innovators - from industry, academia, regulatory and government agencies, health, patient, and philanthropic organizations - conversing about the future of therapeutics, and how they affect you. Click here to watch a brief video and visit here for more information.


Get the full picture

Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription

Watch ACT TV for interviews with
Clinical Trials Experts


Ask the editor

Lisa Henderson
Editor in Chief
lhenderson@advanstar.com

Advertise

Mike Tessalone
Publisher
mtessalone@advanstar.com